General Anesthesia Practice Questions

Q: Which of the following statements about Halothane is FALSE?

Halothane is a good analgesic agent.. **Explanation:** Halothane is a potent inhalational anesthetic agent, but it is characterized by a significant clinical limitation: it is a **potent hypnotic but a poor analgesic**. In clinical practice, this means that while halothane can induce unconsciousness, it does not effectively block pain signals. Therefore, it must be supplemented with other analgesic agents (like opioids or nitrous oxide) to ensure a pain-free surgical state. **Analysis of Options:** * **Option A (Correct):** Halothane provides minimal analgesia. This makes the statement "Halothane is a good analgesic" false. * **Option B:** Halothane sensitizes the myocardium to the effects of circulating catecholamines (epinephrine/norepinephrine). This increases the risk of ventricular arrhythmias, especially if exogenous adrenaline is used during surgery. * **Option C:** Halothane is a potent bronchodilator. It is non-irritating to the airways and inhibits bronchial secretions, making it a historically preferred agent for patients with asthma or COPD. * **Option D:** "Halothane Hepatitis" is a well-known complication. It occurs due to the metabolism of halothane into trifluoroacetylated proteins, which can trigger an immune-mediated hepatotoxicity and centrilobular necrosis. **High-Yield Clinical Pearls for NEET-PG:** * **MAC of Halothane:** 0.75% (highly potent). * **Metabolism:** Approximately 20% is metabolized in the liver (highest among common inhalational agents). * **Uterine Effect:** It causes significant uterine relaxation, which can lead to postpartum hemorrhage (PPH) if used in obstetrics. * **Malignant Hyperthermia:** Like all volatile anesthetics, halothane is a known trigger.

Q: Which muscle relaxant can be used in a patient with high serum bilirubin of 6.0 mg/dL and serum creatinine of 4.5 mg/dL?

Atracurium. **Explanation:** The correct answer is **Atracurium**. The clinical scenario describes a patient with both hepatic impairment (Bilirubin 6.0 mg/dL) and renal failure (Creatinine 4.5 mg/dL). In such cases, the ideal muscle relaxant is one that does not rely on the liver or kidneys for metabolism or excretion. **Why Atracurium is correct:** Atracurium (and its isomer Cisatracurium) undergoes **Hofmann Elimination**—a unique organ-independent chemical degradation that occurs at physiological pH and temperature. It also undergoes ester hydrolysis by non-specific plasma esterases. Because it does not depend on hepatic or renal function, its duration of action remains predictable even in multi-organ failure. **Why other options are incorrect:** * **Vecuronium:** Primarily undergoes hepatic metabolism and biliary excretion (approx. 40-70%). Its duration is significantly prolonged in patients with liver disease. * **Pancuronium:** Primarily excreted by the kidneys (approx. 80%). It would lead to profound neuromuscular blockade and "recurarization" in a patient with a creatinine of 4.5 mg/dL. * **Mivacurium:** While metabolized by plasma cholinesterase, its clearance is significantly delayed in both liver and renal failure due to decreased enzyme production and altered distribution volumes. **NEET-PG High-Yield Pearls:** * **Hofmann Elimination:** Is a temperature and pH-dependent process. Acidosis and hypothermia *slow down* the elimination, prolonging the drug's effect. * **Laudanosine:** A major metabolite of atracurium. It is a CNS stimulant that can lower the seizure threshold (though rarely clinical at standard doses). * **Drug of Choice:** Cisatracurium is often preferred over Atracurium in clinical practice because it produces less histamine release and less laudanosine. * **Renal Failure:** Avoid Gallamine (100% renal excretion) and Pancuronium.

Q: During the second stage of general anesthesia, what is the typical state of the pupil?

Partially dilated. **Explanation:** The stages of anesthesia are described by **Guedel’s Classification**, which tracks the progression of CNS depression. **Stage II (Stage of Delirium/Excitement)** is characterized by a loss of cortical inhibition, leading to a state of sympathetic overactivity. This surge in sympathetic discharge results in physiological responses such as tachycardia, hypertension, irregular breathing, and **pupillary dilation (mydriasis)**. The dilation is typically "partial" because the light reflex remains intact, unlike the paralytic dilation seen in deeper stages. **Analysis of Options:** * **A. Constricted:** This is characteristic of **Stage III, Plane 1** (Surgical Anesthesia). As the patient enters the surgical plane, the sympathetic surge of Stage II subsides, and the pupils become miotic (constricted). * **C. Normal in size:** This is seen in **Stage I** (Analgesia), where the patient is conscious and autonomic reflexes are not yet significantly altered. * **D. Totally dilated:** This occurs in **Stage IV** (Medullary Paralysis/Overdose). Here, the pupils are fixed and dilated due to complete paralysis of the pupillary constrictor muscles, signaling an anesthetic emergency. **NEET-PG High-Yield Pearls:** * **Stage II Danger:** This is the most unstable stage. Risk of laryngospasm, vomiting, and cardiac arrhythmias is highest here. Anesthesiologists aim to pass through this stage as quickly as possible (e.g., using rapid-acting IV agents like Propofol). * **Guedel’s Stages** were originally described using **Diethyl Ether**; they are less distinct with modern IV induction agents but remain a fundamental concept for exams. * **Stage III (Surgical Anesthesia)** is divided into 4 planes; **Plane 2** is generally considered the ideal depth for most surgeries.

Q: Flumazenil is used for reversing the respiratory depression caused by which one of the following drugs?

Midazolam. **Explanation:** **Correct Option: B (Midazolam)** Flumazenil is a specific **competitive antagonist** at the benzodiazepine (BZD) receptor site on the GABA-A receptor complex. Midazolam is a benzodiazepine commonly used for conscious sedation and induction. Flumazenil effectively reverses the sedative, psychomotor, and respiratory-depressant effects caused by BZDs by displacing them from their binding sites. **Why Incorrect Options are Wrong:** * **A. Fentanyl:** This is a potent synthetic opioid. Respiratory depression caused by opioids is reversed by **Naloxone**, a competitive opioid receptor antagonist. * **C. Propofol:** This is an intravenous anesthetic that acts primarily via GABA-A receptors but at a different binding site than BZDs. There is currently **no specific pharmacological reversal agent** for Propofol; management is supportive (ventilation). * **D. Ketamine:** This is a dissociative anesthetic that acts as an **NMDA receptor antagonist**. Like Propofol, it has no specific antagonist. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Flumazenil has a high affinity for BZD receptors but possesses no intrinsic activity (pure antagonist). * **Duration of Action:** Flumazenil has a shorter half-life (~1 hour) than many benzodiazepines (e.g., Diazepam). This can lead to **"re-sedation,"** requiring repeated doses or a continuous infusion. * **Contraindication:** Avoid Flumazenil in patients with long-term BZD use or tricyclic antidepressant (TCA) overdose, as it can precipitate **acute withdrawal seizures**. * **Dose:** The typical initial dose is 0.2 mg IV, titrated up to 1 mg.

Q: Which general anesthetic is most likely to cause bronchodilation?

Ketamine. **Explanation:** **Ketamine** is the correct answer because it is a potent bronchodilator. Its mechanism involves a direct relaxant effect on bronchial smooth muscle and an indirect effect via the inhibition of catecholamine reuptake, which increases circulating adrenaline. This makes Ketamine the **induction agent of choice for patients with reactive airway diseases**, such as bronchial asthma or COPD. **Analysis of Incorrect Options:** * **Thiopentone (Option A):** It is known to cause respiratory depression and can trigger **histamine release**. This may lead to bronchospasm, making it contraindicated in asthmatic patients. * **Propofol (Option C):** While Propofol does produce some bronchodilation (by inhibiting vagal tone and calcium signaling), it is less potent than Ketamine in this regard. It is generally safe for asthmatics but is not the "most likely" to be tested for its bronchodilatory properties compared to Ketamine. * **Fentanyl (Option D):** As an opioid, Fentanyl can cause respiratory depression. High doses or rapid administration can lead to **"Chest Wall Rigidity"** (Wooden Chest Syndrome), which severely impairs ventilation. **High-Yield Clinical Pearls for NEET-PG:** * **Ketamine** is also the induction agent of choice for **hypovolemic shock** due to its sympathomimetic effects (increases HR and BP). * **Avoid Ketamine** in patients with hypertension, ischemic heart disease, or increased intracranial/intraocular pressure. * Among volatile (inhalational) anesthetics, **Sevoflurane** is the most potent bronchodilator and is preferred for gas induction in asthmatics. * **Halothane** also causes bronchodilation but sensitizes the myocardium to catecholamines, increasing the risk of arrhythmias.

Q: Which of the following statements is not true regarding Xenon anesthesia?

It causes slow induction and slow recovery.. **Explanation:** Xenon is an inert noble gas that acts as an ideal anesthetic agent in many respects. The correct answer is **C** because Xenon actually provides **rapid induction and rapid recovery**, not slow. **1. Why Option C is the correct (false) statement:** The speed of induction and recovery of an inhalational anesthetic is inversely proportional to its **blood-gas partition coefficient**. Xenon has an extremely low blood-gas solubility coefficient (**0.115**), which is significantly lower than Desflurane (0.42) or Nitrous Oxide (0.47). This low solubility ensures that the partial pressure in the blood rises and falls very quickly, leading to the fastest induction and emergence among all known inhalational agents. **2. Analysis of incorrect (true) options:** * **Option A:** Xenon is an inert gas; it is non-flammable, non-explosive, and environmentally friendly (no greenhouse effect). * **Option B:** Xenon is remarkably **cardioprotective**. It does not suppress myocardial contractility and maintains stable hemodynamics, making it ideal for high-risk cardiac patients. * **Option D:** As mentioned, its blood-gas solubility is 0.115, which is the lowest of all anesthetic gases. **High-Yield Clinical Pearls for NEET-PG:** * **MAC of Xenon:** Approximately **63–71%** (less potent than volatile liquids but more potent than $N_2O$). * **Mechanism:** Primarily acts via **NMDA receptor antagonism** (unlike most volatiles that act on $GABA_A$). * **Neuroprotection:** It is known for its potent neuroprotective properties. * **Main Limitation:** High cost and the requirement for specialized closed-circuit delivery systems to prevent wastage.

Q: What is the MAC of halothane?

0.75%. **Explanation:** The **Minimum Alveolar Concentration (MAC)** is the concentration of an inhalation anesthetic at 1 atmosphere that prevents skeletal muscle movement in response to a noxious stimulus (surgical incision) in 50% of patients. It is the standard measure of **anesthetic potency**; the lower the MAC, the more potent the agent. **Why 0.75% is correct:** Halothane is a highly lipid-soluble volatile anesthetic with a high oil-gas partition coefficient. Because of its high potency, it requires a very low alveolar concentration to achieve anesthesia. Its standard MAC value is **0.75%**, making it one of the most potent inhalation agents historically used in clinical practice. **Analysis of incorrect options:** * **B (1-2%):** This range corresponds to the MAC of **Isoflurane (1.15%)** and **Enflurane (1.68%)**. * **C (6%):** This is the MAC of **Desflurane (approx. 6.0%)**. Desflurane has low lipid solubility, meaning a much higher concentration is required to achieve the same anesthetic effect as Halothane. * **D (2%):** This is the MAC of **Sevoflurane (approx. 2.0%)**, the most commonly used induction agent in modern pediatric anesthesia. **High-Yield Clinical Pearls for NEET-PG:** * **Potency vs. Speed:** Halothane is the most potent (lowest MAC), but **Desflurane** is the fastest acting (lowest Blood-Gas partition coefficient). * **Halothane Hepatitis:** A rare but serious immune-mediated hepatotoxicity associated with repeated exposure. * **Catecholamine Sensitivity:** Halothane sensitizes the myocardium to epinephrine, increasing the risk of ventricular arrhythmias. * **MAC-Awake:** The concentration at which 50% of patients will open their eyes to command (usually ~0.33 MAC). * **MAC-BAR:** The concentration required to block autonomic responses to incision (usually ~1.5 to 2.0 MAC).

Question 1

Which of the following statements about Halothane is FALSE?

Accepted Answer

Halothane is a good analgesic agent.

Answer

Halothane sensitizes the heart to catecholamines.

Answer

Halothane relaxes the bronchi.

Answer

Halothane causes hepatitis and liver cell necrosis.

Question 2

Which muscle relaxant can be used in a patient with high serum bilirubin of 6.0 mg/dL and serum creatinine of 4.5 mg/dL?

Accepted Answer

Atracurium

Answer

Vecuronium

Answer

Pancuronium

Answer

Mivacurium

Question 3

Wooden chest rigidity is seen with which of the following agents?

Accepted Answer

Fentanyl

Answer

Morphine

Answer

Remifentanyl

Answer

Pentazocine

Question 4

During the second stage of general anesthesia, what is the typical state of the pupil?

Accepted Answer

Partially dilated

Answer

Constricted

Answer

Normal in size

Answer

Totally dilated

Question 5

Which of the following intravenous anesthetic agents' pharmacokinetics does not change significantly with renal and hepatic dysfunction?

Accepted Answer

Propofol

Answer

Thiopentone

Answer

Etomidate

Answer

Ketamine

Question 6

Flumazenil is used for reversing the respiratory depression caused by which one of the following drugs?

Accepted Answer

Midazolam

Answer

Fentanyl

Answer

Propofol

Answer

Ketamine

Question 7

Which general anesthetic is most likely to cause bronchodilation?

Accepted Answer

Ketamine

Answer

Thiopentone

Answer

Propofol

Answer

Fentanyl

Question 8

All of the following statements regarding minimum alveolar concentration (MAC) are true, except one?

Accepted Answer

The rate of induction is dependent on MAC.

Answer

A lower MAC indicates higher potency.

Answer

Nitrous oxide has a MAC value of 104 and is therefore the least potent.

Answer

Methoxyflurane has the lowest MAC value.

Question 9

Which of the following statements is not true regarding Xenon anesthesia?

Accepted Answer

It causes slow induction and slow recovery.

Answer

It is non-explosive.

Answer

It has minimal cardiovascular side effects.

Answer

It has low blood gas solubility.

Question 10

What is the MAC of halothane?

Accepted Answer

0.75%

Answer

1-2%

Answer

6%

Answer

2%

General Anesthesia — MCQs

General Anesthesia — MCQs

On this page

Practice by Chapter

Want unlimited practice?